Personalized Brain Stimulation Systems for Next-Generation Neuromodulation

A revolutionary neuromodulation system that leverages advanced neuroimaging, machine learning, and real-time brain activity feedback to provide highly effective, personalized brain stimulation therapies for a wide range of neurological and psychiatric disorders.

The original patent, 'Systems and methods for targeted neuromodulation', introduced a significant advancement in neuromodulation therapy by generating personalized stimulation targets. However, it has limitations in terms of real-time adaptability, precision, and effectiveness. The new inventive concept addresses these limitations by integrating cutting-edge technologies to create a more sophisticated, adaptive, and patient-centric neuromodulation system.

The new inventive concept consists of a neural network module that generates a personalized brain stimulation therapy plan based on a patient's brain connectivity profile. A stimulation delivery module adapts the therapy plan in real-time to optimize treatment outcomes. The system can be integrated with wearable brain-computer interface devices, cloud-based platforms, and non-invasive optogenetic stimulation devices to provide a comprehensive, adaptive, and highly effective neuromodulation solution.

The new claims introduce a paradigm shift in neuromodulation therapy by incorporating machine learning, real-time brain activity feedback, and advanced neuroimaging. These innovations enable a level of personalization, adaptability, and effectiveness that surpasses the original patent, making the new inventive concept a significant advancement in the field.

Alternative embodiments of the inventive concept could include the use of different machine learning algorithms, integration with various wearable devices, or the development of novel optogenetic stimulation methods. These variations would ensure broad conceptual coverage and provide a foundation for further innovation and development.

The new inventive concept has significant commercial potential in the treatment of neurological and psychiatric disorders, such as depression, anxiety, and Parkinson's disease. The market for neuromodulation therapies is expected to grow substantially in the coming years, and this innovative concept is poised to capture a significant share of that market.